Search Results - "KAMIYA, Sadahiro"

Refine Results
  1. 1

    IL-27 Suppresses CD28-Medicated IL-2 Production through Suppressor of Cytokine Signaling 3 by Owaki, Toshiyuki, Asakawa, Masayuki, Kamiya, Sadahiro, Takeda, Kiyoshi, Fukai, Fumio, Mizuguchi, Junichiro, Yoshimoto, Takayuki

    Published in The Journal of immunology (1950) (01-03-2006)
    “…Abstract IL-27 is a novel IL-6/IL-12 family cytokine that not only plays a role in the early regulation of Th1 differentiation, but also exerts an inhibitory…”
    Get full text
    Journal Article
  2. 2

    Effects of IL-23 and IL-27 on osteoblasts and osteoclasts : inhibitory effects on osteoclast differentiation by KAMIYA, Sadahiro, NAKAMURA, Chika, FUKAWA, Takeshi, ONO, Katsuhiro, OHWAKI, Toshiyuki, YOSHIMOTO, Takayuki, WADA, Seiki

    Published in Journal of bone and mineral metabolism (01-09-2007)
    “…Interleukin (IL)-23 and IL-27 are IL-6/IL-12 family members that play a role in the regulation of T helper 1 cell differentiation. Cytokines are known to be…”
    Get full text
    Journal Article
  3. 3

    The Promoting Effect of the Extracellular Matrix Peptide TNIIIA2 Derived from Tenascin-C in Colon Cancer Cell Infiltration by Suzuki, Hideo, Sasada, Manabu, Kamiya, Sadahiro, Ito, Yuka, Watanabe, Hikaru, Okada, Yuko, Ishibashi, Kazuma, Iyoda, Takuya, Yanaka, Akinori, Fukai, Fumio

    “…The extracellular matrix (ECM) molecule tenascin C (TNC) is known to be highly expressed under various pathological conditions such as inflammation and cancer…”
    Get full text
    Journal Article
  4. 4

    Potent antitumor activity of interleukin-27 by HISADA, Masayuki, KAMIYA, Sadahiro, FUJITA, Koji, BELLADONNA, Maria Laura, AOKI, Tatuya, KOYANAGI, Yasuhisa, MIZUGUCHI, Junichiro, YOSHIMOTO, Takayuki

    Published in Cancer research (Chicago, Ill.) (01-02-2004)
    “…Although much promising data that interleukin (IL)-12 could be a powerful therapeutic agent against cancer were reported in animal models, its excessive…”
    Get full text
    Journal Article
  5. 5

    Induction of IgG2a Class Switching in B Cells by IL-27 by Yoshimoto, Takayuki, Okada, Keiko, Morishima, Noriko, Kamiya, Sadahiro, Owaki, Toshiyuki, Asakawa, Masayuki, Iwakura, Yoichiro, Fukai, Fumio, Mizuguchi, Junichiro

    Published in The Journal of immunology (1950) (15-08-2004)
    “…IL-27 is a novel IL-12 family member that plays a role in the early regulation of Th1 initiation. However, its role in B cells remains unexplored. We here show…”
    Get full text
    Journal Article
  6. 6

    Adjuvant Activities of Novel Cytokines, Interleukin-23 (IL-23) and IL-27, for Induction of Hepatitis C Virus-Specific Cytotoxic T Lymphocytes in HLA-A0201 Transgenic Mice by MATSUI, Masanori, MORIYA, Osamu, BELLADONNA, Maria Laura, KAMIYA, Sadahiro, LEMONNIER, Francois A, YOSHIMOTO, Takayuki, AKATSUKA, Toshitaka

    Published in Journal of Virology (01-09-2004)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Involvement of hepatocyte growth factor in the development of bone metastasis of a mouse mammary cancer cell line, BALB/c-MC by Ono, Katsuhiro, Kamiya, Sadahiro, Akatsu, Takuhiko, Nakamura, Chika, Li, Minqi, Amizuka, Norio, Matsumoto, Kunio, Nakamura, Toshikazu, Kugai, Nobuo, Wada, Seiki

    Published in Bone (New York, N.Y.) (01-07-2006)
    “…Some cancers frequently affect the skeleton, and the bone microenvironment supports growth of certain cancer cells. After tumors metastasize to bone, they…”
    Get full text
    Journal Article
  9. 9

    Antiadhesive Sites Present in the Fibronectin Type III-Like Repeats of Human Plasma Fibronectin by Miura, Shogo, Kamiya, Sadahiro, Saito, Yohei, Wada, Seiki, Hayashi, Ryo, Taira, Junichi, Kodama, Hiroaki, Yajima, Hirofumi, Ueki, Masaaki, Fukai, Fumio

    Published in Biological & pharmaceutical bulletin (01-05-2007)
    “…We have found that fibronectin (FN) has a functional cryptic site opposing cell adhesion to extracellular matrix (ECM): a synthetic FN peptide derived from the…”
    Get full text
    Journal Article
  10. 10

    A New Type of Antimetastatic Peptide Derived from Fibronectin by Kato, Rina, Ishikawa, Tetsuya, Kamiya, Sadahiro, Oguma, Fumiko, Ueki, Masaaki, Goto, Sumio, Nakamura, Hiroshi, Katayama, Takashi, Fukai, Fumio

    Published in Clinical cancer research (01-07-2002)
    “…Purpose: We found previously that fibronectin (FN) has a cryptic functional site (YTIYVIAL sequence within the 14th type III repeat) opposing cell adhesion to…”
    Get full text
    Journal Article
  11. 11

    Biochemical markers of bone turnover. New aspect. Bone metabolic markers available in daily practice by Wada, Seiki, Fukawa, Takeshi, Kamiya, Sadahiro

    Published in Clinical calcium (01-08-2009)
    “…Changes of bone remodeling markers reflect bone growth and bone turnover. Information on bone metabolism can be attained by blood and urine laboratory tests…”
    Get more information
    Journal Article
  12. 12

    Osteocalcin and bone by Wada, Seiki, Fukawa, Takeshi, Kamiya, Sadahiro

    Published in Clinical calcium (01-11-2007)
    “…Osteocalcin (OC) is a product of osteoblasts and accumulated in the extracellular matrix of bone. It has been recognized that serum OC is a marker of…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Synergistic antitumor effect by coexpression of chemokine CCL21 SLC and costimulatory molecule LIGHT by Hisada, Masayuki, Yoshimoto, Takayuki, Kamiya, Sadahiro, Magami, Yasushi, Miyaji, Hiroko, Yoneto, Toshihiko, Tamada, Koji, Aoki, Tatuya, Koyanagi, Yasuhisa, Mizuguchi, Junichiro

    Published in Cancer gene therapy (01-04-2004)
    “…To establish a more efficient treatment for immunotherapy against solid tumors, we have evaluated the antitumor effect by coexpression of a chemokine…”
    Get full text
    Journal Article
  15. 15

    Bone and bone related biochemical examinations. Bone and collagen related metabolites. Osteocalcin (OC) by Wada, Seiki, Kamiya, Sadahiro

    Published in Clinical calcium (01-06-2006)
    “…Osteocalcin is produced by mature osteoblasts and primarily deposited in the extracellular matrix of skeletal tissue. It has been shown that serum osteocalcin…”
    Get more information
    Journal Article
  16. 16

    Bone quality changes in diabetes by Wada, Seiki, Kamiya, Sadahiro, Fukawa, Takeshi

    Published in Clinical calcium (01-05-2008)
    “…Diabetes-related bone fragility has recently drawn many researchers' attention. Diabetes would affect bone remodeling by various mechanisms, including…”
    Get more information
    Journal Article
  17. 17

    Newly developed drugs for osteoporosis in overseas and their future roles for the therapy by Wada, Seiki, Fukawa, Takeshi, Kamiya, Sadahiro

    Published in Clinical calcium (01-10-2008)
    “…Bisphosphonates are widely used, though gastrointestinal tolerance is a problem on daily administration. Intermittent regimen, from once weekly to once yearly,…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis by Wada, Seiki, Fukawa, Takeshi, Kamiya, Sadahiro

    Published in Clinical calcium (01-12-2007)
    “…Parathyroid hormone (PTH) is a new management option for patients with osteoporosis. As an anabolic agent that affects bone remodeling and modeling, a novel…”
    Get more information
    Journal Article